DNA Methylation: Epigenetics in the wild

  1. Adam J Bewick
  2. Robert J Schmitz   Is a corresponding author
  1. University of Georgia, United States

Individuals of the same species often carry the same genes but with slight differences. Each version of a gene is called an allele, and individuals with certain alleles can display certain traits or characteristics that will give them, within their local environment, a fitness advantage over individuals with different alleles. How genes underlie this ‘local adaptation’ and how natural selection shapes this process have been actively researched since the middle of the last century (Orr, 2005). In recent years, however, it has emerged that there are heritable traits that are not the direct result of differences in DNA sequences. These epigenetic variations can also provide the raw materials for natural selection to occur (Eitchen et al., 2014).

DNA molecules can be very long; as a result they are wrapped around proteins called histones so that they can be easily packed inside a cell's nucleus. Both DNA and the histone proteins can be chemically modified, and alleles with the same DNA sequence but different patterns of chemical modifications (called ‘epialleles’) can be passed between generations and contribute to complex traits or characteristics (Cortijo et al., 2014). Now in eLife, Magnus Nordborg and co-workers—from Austria, the US, the UK and Germany—have explored variations in DNA methylation among wild populations of a plant called Arabidopsis thaliana in Sweden to see how epigenetic variation is influenced by the local environment (Dubin et al., 2015).

Methylation is a chemical modification to DNA that inhibits the proliferation of selfish DNA elements (such as transposable elements) and helps regulate gene expression. Several proteins and enzymes work together in pathways to establish and maintain DNA methylation at sites with one of the following DNA sequences: CG, CHG (where H can be an A, T or C base) or CHH (Law and Jacobsen, 2010).

One pathway is responsible for ‘gene body methylation’, which involves the methylation of DNA within a large subset of genes, but only at CG sites. However, transposable elements can be methylated by multiple pathways: one pathway important to this study involves the enzyme CMT2, which methylates long or ‘deep’ transposable elements at CHG and CHH sites (Zemach et al., 2013; Stroud et al., 2014). In this case, ‘deep’ refers to transposable elements that are within tightly packed (or heterochromatic) regions of the genome.

Patterns of DNA methylation at regions within both genes and transposable elements vary extensively within and among natural Arabidopsis populations (Schmitz et al., 2013). However, the potential effects of this epigenetic variation on fitness and local adaptation remain unclear. Nordborg and co-workers—who include Manu Dubin, Pei Zhang, Dazhe Meng and Marie-Stanislas Remigereau as joint first authors—found that DNA methylation at CHH sites in transposable elements increases with temperature (Dubin et al., 2015, Figure 1A). Using CHH methylation as a trait, Nordborg and co-workers then conducted a genome-wide search and revealed that, in general, a lot of the variation in this trait could be explained by which allele the plant carried at a specific site called CMT2a (Figure 1B). This site is near a gene that encodes an enzyme called CMT2, which is known to methylate CHG and CHH sites in long transposable elements (Zemach et al., 2013; Stroud et al., 2014). All the plants examined carried one of two possible alleles (that differed by a single DNA base). Furthermore, plants with the less common of the two alleles—called the ‘non-reference allele’—typically had more CHH methylation than plants with the more common reference allele. Additional searches revealed another similar site nearby, called CMT2b. In this case plants with the rarer non-reference allele had less CHH methylation on average.

DNA methylation responds to temperature changes.

(A) Methylation at CHH sites across the whole genome is higher in plants that are grown at higher temperatures. (B) Individual plants with different genotypes (that is, in plants with different combinations of alleles) for the gene that encodes the CMT2 enzyme show different levels of CHH methylation in long transposable elements. For example plants with non-reference (nr) alleles at CMT2a and reference (r) alleles at CMT2b display a high rate of CHH methylation. (C) Plants originating from northern regions of Sweden (high latitude of origin) have higher levels of gene-body methylation and overall gene expression than plants originally from southern Sweden.

The two pairs of alleles were found in populations of Arabidopsis from both southern and northern Sweden, but the non-reference alleles were more common in southern regions. This may indicate that there is gene flow between populations, or that natural selection is still ‘in action’ and continues to select for one allele over the other but has not yet ‘fixed’ the alleles between populations. Together with other recent results (Shen et al., 2014), these latest findings indicate that the temperature-dependent CHH methylation is a flexible trait, and that certain alleles that encode the CMT2 enzyme may make plant genomes more responsive to environmental changes.

In addition to CHH methylation, Nordborg and co-workers also observed a correlation between gene body methylation and the latitude of origin (Figure 1C). Specifically, populations from northern regions had higher levels of gene body methylation. Genes that are more heavily methylated in the northern regions are expressed at higher levels compared to their less methylated counterparts in the south.

This work is a first step on the way to a full understanding of how environment and genetic makeup contribute to the variation in DNA methylation observed in wild populations. The work also suggests that genetic variation at enzymes involved in DNA methylation may provide some populations with an advantage to changing environmental conditions or seasons.

Future experiments, including moving wild plants between different populations and then assessing their fitness, would shed more light on DNA methylation and its role in local adaptation. Likewise, comparisons between individuals of different species could unveil other types of naturally occurring diversity and provide a wealth of genetic or genomic resources to help us better understand DNA methylation in the light of evolutionary biology. Furthermore, studies within a species could help determine how much variation in physical traits is controlled by DNA methylation variation as opposed to genetic variation. In this scenario each genome-wide difference in DNA methylation is used as a marker and tested for an association with the trait under study. However, differences in DNA methylation markers between different populations due to demographic factors would confound these studies, making it difficult to determine the underlying epigenetic variation that contributes to the traits.

Research into DNA methylation (and epigenetics in general) has only recently begun in the natural sciences. Understanding the relationship between an organism's fitness and its epigenetics, traits and environment represents a challenging, but fruitful, area of future research.

References

Article and author information

Author details

  1. Adam J Bewick

    Department of Genetics, University of Georgia, Athens, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Robert J Schmitz

    Department of Genetics, University of Georgia, Athens, United States
    For correspondence
    schmitz@uga.edu
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: May 5, 2015 (version 1)

Copyright

© 2015, Bewick and Schmitz

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,299
    views
  • 363
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Adam J Bewick
  2. Robert J Schmitz
(2015)
DNA Methylation: Epigenetics in the wild
eLife 4:e07808.
https://doi.org/10.7554/eLife.07808

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Bohan Zhu, Richard I Ainsworth ... Javier González-Maeso
    Research Article

    Genome-wide association studies have revealed >270 loci associated with schizophrenia risk, yet these genetic factors do not seem to be sufficient to fully explain the molecular determinants behind this psychiatric condition. Epigenetic marks such as post-translational histone modifications remain largely plastic during development and adulthood, allowing a dynamic impact of environmental factors, including antipsychotic medications, on access to genes and regulatory elements. However, few studies so far have profiled cell-specific genome-wide histone modifications in postmortem brain samples from schizophrenia subjects, or the effect of antipsychotic treatment on such epigenetic marks. Here, we conducted ChIP-seq analyses focusing on histone marks indicative of active enhancers (H3K27ac) and active promoters (H3K4me3), alongside RNA-seq, using frontal cortex samples from antipsychotic-free (AF) and antipsychotic-treated (AT) individuals with schizophrenia, as well as individually matched controls (n=58). Schizophrenia subjects exhibited thousands of neuronal and non-neuronal epigenetic differences at regions that included several susceptibility genetic loci, such as NRG1, DISC1, and DRD3. By analyzing the AF and AT cohorts separately, we identified schizophrenia-associated alterations in specific transcription factors, their regulatees, and epigenomic and transcriptomic features that were reversed by antipsychotic treatment; as well as those that represented a consequence of antipsychotic medication rather than a hallmark of schizophrenia in postmortem human brain samples. Notably, we also found that the effect of age on epigenomic landscapes was more pronounced in frontal cortex of AT-schizophrenics, as compared to AF-schizophrenics and controls. Together, these data provide important evidence of epigenetic alterations in the frontal cortex of individuals with schizophrenia, and remark for the first time on the impact of age and antipsychotic treatment on chromatin organization.

    1. Cancer Biology
    2. Genetics and Genomics
    Kevin Nuno, Armon Azizi ... Ravindra Majeti
    Research Article

    Relapse of acute myeloid leukemia (AML) is highly aggressive and often treatment refractory. We analyzed previously published AML relapse cohorts and found that 40% of relapses occur without changes in driver mutations, suggesting that non-genetic mechanisms drive relapse in a large proportion of cases. We therefore characterized epigenetic patterns of AML relapse using 26 matched diagnosis-relapse samples with ATAC-seq. This analysis identified a relapse-specific chromatin accessibility signature for mutationally stable AML, suggesting that AML undergoes epigenetic evolution at relapse independent of mutational changes. Analysis of leukemia stem cell (LSC) chromatin changes at relapse indicated that this leukemic compartment underwent significantly less epigenetic evolution than non-LSCs, while epigenetic changes in non-LSCs reflected overall evolution of the bulk leukemia. Finally, we used single-cell ATAC-seq paired with mitochondrial sequencing (mtscATAC) to map clones from diagnosis into relapse along with their epigenetic features. We found that distinct mitochondrially-defined clones exhibit more similar chromatin accessibility at relapse relative to diagnosis, demonstrating convergent epigenetic evolution in relapsed AML. These results demonstrate that epigenetic evolution is a feature of relapsed AML and that convergent epigenetic evolution can occur following treatment with induction chemotherapy.